FDA OKs Ariad's drug for two rare blood cancers

FDA OKs Ariad's drug for two rare blood cancers: (Reuters) - The U.S. Food and Drug Administration said on Friday it approved Ariad Pharmaceuticals Inc's drug to treat two rare types of blood cancer, three months ahead of the review date.